Endocrinology Medical News about Pioglitazone

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pioglitazone vs glimepiride: Differential effects on vascular endothelial function in patients with type 2 diabetes
Atherosclerosis, 06/25/09

Papathanassiou K et al. - In patients with type 2 diabetes already on metformin, addition of pioglitazone as compared to glimepiride, improved endothelial function despite similar glycemic control. The improvement in endothelial function was mainly due to a reduction in insulin resistance.

<< Previous
Diabetes Experts Recommend A1c Testing for Diabetes Diagnosis

Next >>
Parathyroid Incidentalomas Detected on Routine...

Pioglitazone Induced Reversible Pancytopenia
Experimental and Clinical Endocrinology & Diabetes, 11/02/09 Relevance Score: 88%

Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM
Current Medical Research and Opinion, 10/22/09 Relevance Score: 88%

Long-term effects of pioglitazone in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity
Current Medical Research and Opinion, 10/19/09 Relevance Score: 87%

Long-term glycaemic control with metformin–sulphonylurea–pioglitazone triple therapy in PROactive (PROactive 17)
Diabetic Medicine, 10/02/09 Relevance Score: 87%

Pioglitazone Treatment Enlarges Subcutaneous Adipocytes in Insulin-Resistant Patients
Journal of Clinical Endocrinology and Metabolism, 10/15/09 Relevance Score: 85%